Dana Pharmaceutical Company
Dana Pharmaceutical Company
Dana Pharmaceutical Company is a listed Tabriz-based pharmaceutical manufacturer and one of Iran's major antibiotic and soft-gel producers. In the Hormuz Group company graph, it matters because it connects East Azerbaijan's industrial base, API production, finished antibiotic supply, sterile production, pharmaceutical exports, listed-company disclosure, and import substitution in medicine manufacturing. Its scale makes it relevant to both healthcare access and capital-market monitoring.
Products & Services
Dana Pharmaceutical Company manufactures active pharmaceutical ingredients and finished pharmaceutical products, with emphasis on antibiotic APIs, oral and sterile antibiotics, injectable vials, soft-gel capsules, hard capsules, tablets, oral suspensions, sterile drops, sterile water for injection, eye drops, cardiovascular products, gastrointestinal products, supplements, and selected biotechnology or pharmaceutical development categories.
Investment Relevance
Dana Pharmaceutical is relevant for investors assessing Iran's listed pharmaceutical sector, antibiotic API localization, sterile-drug capacity, export potential, healthcare supply resilience, and the economics of large drug manufacturers outside Tehran. It can support analysis of medicine shortages, API dependence, pricing regulation, distributor receivables, GMP standards, and foreign-currency exposure. Due diligence should review updated Codal disclosures, production-line utilization, API sourcing, export registrations, product mix, regulatory compliance, quality certifications, working capital, shareholder structure, energy and water reliability, and exposure to sanctions-related payment or supplier constraints.
Connected Intelligence
This profile is connected to Hormuz taxonomy layers across geography, industry, market exposure, and investment constraints.
Source & Verification Note
Based on public company, official-company, pharmaceutical-sector, API, antibiotic, market, and disclosure-related information. Further verification is required before treating this profile as verified investment intelligence.